BB Biotech AG (ETR:BBZA)
Germany
· Delayed Price · Currency is EUR 29.90
-0.40 (-1.32%)
Apr 25, 2025, 10:34 AM CET
-29.23% (1Y)
| Fund Assets | n/a |
| Expense Ratio | n/a |
| Min. Investment | n/a |
| Turnover | n/a |
| Dividend (ttm) | 1.88 |
| Dividend Yield | 6.46% |
| Dividend Growth | n/a |
| Payout Frequency | Annual |
| Ex-Dividend Date | Mar 21, 2025 |
| Previous Close | 30.30 |
| YTD Return | -15.52% |
| 1-Year Return | -25.11% |
| 5-Year Return | -32.63% |
| 52-Week Low | n/a |
| 52-Week High | n/a |
| Beta (5Y) | 0.90 |
| Holdings | n/a |
| Inception Date | n/a |
About BBZA
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
Country Switzerland
Stock Exchange Deutsche Börse Xetra
Ticker Symbol BBZA
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Mar 21, 2025 | €1.88109 | Mar 25, 2025 |
| Mar 25, 2024 | €2.05928 | Mar 27, 2024 |
| Mar 27, 2023 | €2.88683 | Mar 29, 2023 |
| Mar 21, 2022 | €3.73137 | Mar 23, 2022 |
| Mar 22, 2021 | €3.2519 | Mar 24, 2021 |
| Mar 23, 2020 | €3.22413 | Mar 25, 2020 |